Pardes Biosciences Deck Pardes Biosciences, an agile biopharmaceutical company, develops oral antiviral drug to treat and prevent SARS-CoV-2 infections. Debarshi Ghosh 29 Jun 2021 Share on Twitter Share on Facebook Share on LinkedIn Share on Pinterest Share via Email Copy link This post is for subscribers only Subscribe Already have an account? Log in